Los Angeles Capital Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.35M | Buy |
|
|||||
|
2025
Q2 | $1.47M | Sell |
|
|||||
|
2025
Q1 | $1.59M | Buy |
|
|||||
|
2024
Q4 | $1.5M | Sell |
|
|||||
|
2024
Q3 | $2.21M | Sell |
|
|||||
|
2024
Q2 | $1.93M | Sell |
|
|||||
|
2024
Q1 | $2.56M | Sell |
|
|||||
|
2023
Q4 | $2.17M | Sell |
|
|||||
|
2023
Q3 | $1.72M | Buy |
|
|||||
|
2023
Q2 | $1.64M | Buy |
|
|||||
|
2023
Q1 | $1.71M | Sell |
|
|||||
|
2022
Q4 | $2.16M | Sell |
|
|||||
|
2022
Q3 | $2.23M | Buy |
|
|||||
|
2022
Q2 | $2.18M | Buy |
|
|||||
|
2022
Q1 | $2.03M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $517K | Sell |
|
|||||
|
2021
Q1 | $547K | Sell |
|
|||||
|
2020
Q4 | $860K | Sell |
|
|||||
|
2020
Q3 | $927K | Sell |
|
|||||
|
2020
Q2 | $796K | Buy |
|
|||||
|
2020
Q1 | $610K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $384K | Buy |
|